Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.77891 | 33 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.79695 | 35 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.75013 | 33 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.65102 | 31 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.65386 | 31 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.80998 | 32 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.06041 | 43 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.73542 | 33 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.67219 | 31 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.74857 | 34 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.74354 | 33 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.70668 | 32 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.84283 | 37 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.96603 | 42 |